ストックスクリーナーアプリを入手
27.09
9.31%
-2.78
アフターアワーズ：
27.11
0.02
+0.07%
前日終値:
$29.87
開ける：
$29.4
24時間の取引高:
21.83M
Relative Volume:
1.18
時価総額：
$6.17B
収益：
$1.78B
当期純損益:
$164.40M
株価収益率:
39.26
EPS:
0.69
ネットキャッシュフロー:
$236.51M
1週間 パフォーマンス:
-8.54%
1か月 パフォーマンス:
-18.01%
6か月 パフォーマンス:
-58.66%
1年 パフォーマンス:
-20.23%
1日の値動き範囲:
$26.87
$30.27
1週間の範囲:
$26.87
$30.95
52週間の値動き範囲:
$23.97
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
HIMS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
27.09 | 6.80B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
124.82 | 53.64B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.23 | 54.24B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
HLN
Haleon Plc Adr
|
10.47 | 45.87B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.08 | 37.94B | 17.39B | 1.43B | 774.28M | 1.219 |
|
UTHR
United Therapeutics Corp
|
469.49 | 20.14B | 3.13B | 1.27B | 1.12B | 26.39 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-12 | 開始されました | Evercore ISI | In-line |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-10-21 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | ダウングレード | Needham | Buy → Hold |
| 2025-06-04 | 繰り返されました | Needham | Buy |
| 2025-04-29 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-01-07 | 開始されました | BTIG Research | Buy |
| 2024-12-17 | 開始されました | Morgan Stanley | Overweight |
| 2024-11-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-08-22 | 開始されました | Needham | Buy |
| 2024-08-09 | ダウングレード | Imperial Capital | Outperform → In-line |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-04-16 | ダウングレード | Jefferies | Buy → Hold |
| 2024-04-10 | 開始されました | Canaccord Genuity | Buy |
| 2024-02-28 | アップグレード | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-07 | 開始されました | Imperial Capital | In-line |
| 2023-07-28 | 開始されました | TD Cowen | Outperform |
| 2023-04-11 | 開始されました | Robert W. Baird | Neutral |
| 2023-02-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-07-15 | 開始されました | SVB Leerink | Underperform |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-10 | 開始されました | Deutsche Bank | Hold |
| 2021-12-02 | 開始されました | Jefferies | Hold |
| 2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 開始されました | BofA Securities | Neutral |
| 2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 開始されました | Truist | Hold |
| 2021-03-09 | 開始されました | Credit Suisse | Neutral |
| 2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | 開始されました | Citigroup | Neutral |
| 2021-02-12 | 開始されました | Piper Sandler | Neutral |
| 2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
Hims and Hers Super Bowl ad highlights ‘uncomfortable truth’ about elite healthcare for the rich and ‘broken’ system for the rest - Yahoo Finance
Hims & Hers Bets Big on Provocative Super Bowl Ad Strategy - AD HOC NEWS
OMCL or HIMS: Which Is the Better Value Stock Right Now? - Yahoo Finance
Hims & Hers returns with another Super Bowl ad one year after controversy - Medical Marketing and Media
Hims & Hers: A Platform Strategy Pivot Driving Long-Term Value (NYSE:HIMS) - Seeking Alpha
Hims’ Super Bowl Ad Cost $16 Million and Nearly a Year’s Worth of Effort - inc.com
Assessing Hims & Hers Health (HIMS) Valuation As Estimate Cuts And Big Game Ad Campaign Shape Sentiment - simplywall.st
Hims & Hers Wants To ‘Ruffle Some Feathers’ With Provocative Super Bowl Ad - Athletech News
HIMS Stock Sees Surge in Call Option Activity - GuruFocus
Super Bowl updates—see Hims, Novartis, Pepsi and Toyota’s full spots - Ad Age
Hims & Hers Super Bowl Commercial Spotlights Cancer Detection, Glp-1 Microdoses - IMDb
Health care and pharma brands are going all-in on the Super Bowl—behind the growing trend - Ad Age
Hims & Hers Returns to the Big Game with a Message to All Americans: The Era of Health as a Luxury is Over - Hims Investor Relations
Hims & Hers attacks the rich in its Super Bowl ad — including a Jeff Bezos lookalike - Business Insider
The Health Gap is a Wealth Gap. That Stops next Sunday. - Hims & Hers Newsroom
Hims & Hers Returns To Super Bowl With Ad That Spotlights The Health-Wealth Gap - Forbes
Hims & Hers: It's Time To Get Aggressive (NYSE:HIMS) - Seeking Alpha
Jack Abraham Board Role Links Hims And Hers To Research Frontline - Sahm
Surging Q3 Revenue And Cash Pile Could Be A Game Changer For Hims & Hers Health (HIMS) - Yahoo Finance
Cold Spring Harbor Laboratory Appoints Jack Abraham and Terri Keogh to Board of Trustees - Yahoo Finance Singapore
Hims & Hers Health, Inc. (HIMS) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
HIMS Stock Sees Bearish Sentiment Amidst Increased Volatility - GuruFocus
Looking At Hims & Hers Health's Recent Unusual Options Activity - Benzinga
Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now? - Yahoo Finance
Noteworthy Monday Option Activity: SKYT, CLOV, HIMS - Nasdaq
Kelley Drye Expands Privacy Practice with Partner Kate Black and Special Counsel Mason Fitch - GlobeNewswire Inc.
Hims & Hers Stock Approaches a Pivotal Juncture - AD HOC NEWS
Hims & Hers Scales Platform-Led Digital Healthcare Access and Care - Nasdaq
Q3 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks - Finviz
Assessing Hims & Hers Health (HIMS) Valuation After Recent Share Price Volatility - Yahoo Finance
Telehealth Stock Popular With Bulls Despite Underperformance - Schaeffer's Investment Research
Hims & Hers Health: The Reset Nobody Expected (NYSE:HIMS) - Seeking Alpha
Y Intercept Hong Kong Ltd Grows Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
A Profitable Company Under Siege: The Curious Case of Hims & Hers - AD HOC NEWS
End Of Novo Nordisk GLP-1 Deal Could Be A Game Changer For Hims & Hers Health (HIMS) - Sahm
Peering Into Hims & Hers Health Inc's Recent Short Interest - Sahm
Hims & Hers Health Stock Outlook: Modeling a 95% Upside Case - TIKR.com
Lobbying Update: $330,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed - Quiver Quantitative
Healthcare Stocks To Keep An Eye OnJanuary 23rd - MarketBeat
Steadview Capital Management LLC Purchases 311,845 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
TipRanksXAI Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Cuts Target Price to $31 - Futubull
183,304 Shares in Hims & Hers Health, Inc. $HIMS Acquired by Emerald Mutual Fund Advisers Trust - MarketBeat
Hims Hair Loss Solutions: Will the Convenient Option Work for You? - The National Council on Aging (NCOA)
How (HIMS) Movements Inform Risk Allocation Models - Stock Traders Daily
What are the hidden costs of weight loss for Americans? - leader-call.com
HIMS vs. TEM: Which Health-Tech Stock Looks More Compelling? - Finviz
Healthcare Stocks To ConsiderJanuary 22nd - MarketBeat
Why Hims & Hers Stock Slipped Today - AOL.com
QRG Capital Management Inc. Decreases Stock Holdings in Hims & Hers Health, Inc. $HIMS - MarketBeat
Emerald Advisers LLC Acquires New Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Okupe, CFO of Hims & Hers, sells $275k in HIMS stock By Investing.com - Investing.com South Africa
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
1.13%
0.50%
大文字化:
|
ボリューム (24 時間):